AstraZeneca has announced it is withdrawing its COVID-19 vaccine from the market worldwide due to a decline in demand, despite the company having identified a rare risk of dangerous blood clots associated with the vaccine in 2021.
The post Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine appeared first on The Washington Informer.
